# US 2010/0168173 A1 · Heterocycles substituted pyridine derivatives and antifungal agent containing thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168173 A1
- Document ID: US20100168173A1
- Status: Published application
- Kind: A1
- Application number: 12/704,637
- Filed: 2010-02-12
- Published: 2010-07-01
- Earliest claimed: 2005-10-31
- Assignees: Eisai R&D Management Co., Ltd.
- Inventors: Keigo Tanaka; Satoshi Inoue; Norio Murai; Masayuki Matsukura; Kazutaka Nakamoto; Shuji Shirotori; Shinya Abe
- Web page: https://patentgrep.com/patent/US20100168173A1

## CPC

- A01N 43/56: 1,2-Diazoles; Hydrogenated 1,2-diazoles
- A01N 43/80: five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/10: Antimycotics
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 401/14: containing three or more hetero rings
- C07D 413/04: directly linked by a ring-member-to-ring-member bond
- C07D 413/14: containing three or more hetero rings
- C07D 417/14: containing three or more hetero rings
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

An object of the present invention is to provide an antifungal agent which has excellent antifungal effects and is superior in terms of its physical properties, safety and metabolic stability. According to the present invention, there is disclosed a compound represented by the following formula (I), or a salt thereof: wherein R1 represents a hydrogen atom, a halogen atom, an amino group, a C1-6 alkyl group, a C1-6 alkoxy group or a C1-6 alkoxy C1-6 alkyl group; R2 represents a hydrogen atom, a C1-6 alkyl group, an amino group or a di C1-6 alkylamino group; one of X and Y is a nitrogen atom while the other is a nitrogen atom or an oxygen atom; ring A represents a 5- or 6-member heteroaryl ring or a benzene ring which may have a halogen atom, or 1 or 2 C1-6 alkyl groups; Z represents a single bond, a methylene group, an ethylene group, an oxygen atom, a sulfur atom, —CH2O—, —OCH2—, —NH—, —CH2NH—, —NHCH2—, —CH2S—, or —SCH2—; R3 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group, a C3-8 cycloalkyl group, a C6-10 aryl group, a 5- or 6-member heteroaryl group, or 5- or 6-member non-aromatic heterocyclic group which may have 1 or 2 substituents; and R4 represents a hydrogen atom or a halogen atom.

## Claims

### Claim 1

A compound represented by the following formula (I), or a salt thereof:
wherein R1 represents a hydrogen atom, a halogen atom, an amino group, R11—NH— (wherein R11 represents a C1-6 alkyl group, a hydroxy C1-6 alkyl group, a C1-6 alkoxy C1-6 alkyl group, or a C1-6 alkoxycarbonyl C1-6 alkyl group), R12—(CO)—NH— (wherein R12 represents a C1-6 alkyl group or a C1-6 alkoxy C1-6 alkyl group), a C1-6 alkyl group, a hydroxy C1-6 alkyl group, a cyano C1-6 alkyl group, a C1-6 alkoxy group or a C1-6 alkoxy C1-6 alkyl group;
R2 represents a hydrogen atom, a C1-6 alkyl group, an amino group or a di C1-6 alkylamino group;
X is an oxygen atom;
Y is a nitrogen atom;
ring A represents a benzene ring which may have 1 or 2 halogen atoms, or 1 or 2 C1-6 alkyl groups;
Z represents a single bond, a methylene group, an ethylene group, an oxygen atom, a sulfur atom, —CH2O—, —OCH2—, —NH—, —CH2NH—, —NHCH2—, —CH2S—, or —SCH2—;
R3 represents a hydrogen atom, or a halogen atom, or a C1-6 alkyl group, a C3-8 cycloalkyl group, a C6-10 aryl group, a 5- or 6-membered heteroaryl group, or 5- or 6-membered non-aromatic heterocyclic group, wherein these groups may have 1 or 2 substituents selected from substituent group α,
wherein substituent group α represents the group consisting of a halogen atom, a cyano group, a C1-6 alkyl group, a C1-6 alkoxy group, a C1-6 alkoxycarbonyl group, a C3-8 cycloalkyl group, a C2-6 alkenyl group and a C2-6 alkynyl group; and
R4 represents a hydrogen atom or a halogen atom;
excluding compounds where all of R1, R2, and R4 represent the hydrogen atom at the same time when Z represents the single bond or R3 represents the hydrogen atom.

### Claim 2 (depends on 1)

The compound or a pharmaceutically acceptable salt thereof according to claim 1, wherein Z represents an oxygen atom.

### Claim 3 (depends on 1)

The compound or a pharmaceutically acceptable salt thereof according to claim 1, wherein R1 represents an amino group.

### Claim 4 (depends on 1)

The compound or a pharmaceutically acceptable salt thereof according to claim 1, wherein R2 represents an amino group.

### Claim 5 (depends on 1)

The compound or a pharmaceutically acceptable salt thereof according to claim 1, wherein R3 represents a C6-10 aryl group that may have 1 or 2 substituents selected from substituent group α.

### Claim 6 (depends on 1)

The compound or a pharmaceutically acceptable salt thereof according to claim 1, wherein R3 represents benzene.

### Claim 7 (depends on 1)

The compound or a pharmaceutically acceptable salt thereof according to claim 1, wherein R4 represents a hydrogen atom.

### Claim 8 (depends on 1)

A pharmaceutical composition comprising the compound or the salt thereof according to claim 1; and
a pharmaceutically acceptable carrier.

### Claim 9

A compound or a pharmaceutically acceptable salt thereof, said compound is selected from the group consisting of:
3-(3-(4-benzyloxy-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine,
3-(3-(4-benzyloxy-benzyl)-isoxazol-5-yl)-pyridin-2,6-diamine,
3-(3-(4-phenylaminomethyl-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine, and
3-(3-(4-phenoxy-benzyl)-isoxazol-5-yl)-pyridin-2,6-diamine.

### Claim 10 (depends on 9)

A pharmaceutical composition comprising the compound or the salt thereof according to claim 9; and
a pharmaceutically acceptable carrier.

### Claim 11

A compound of 3-(3-(4-benzyloxy-benzyl)-isoxazol-5-yl)-pyridin-2,6-diamine:
or a pharmaceutically acceptable salt thereof.

### Claim 12 (depends on 11)

A pharmaceutical composition comprising the compound or the salt thereof according to claim 11; and
a pharmaceutically acceptable carrier.

### Claim 13 (depends on 1)

A method for treating a fungal infection comprising:
administering a pharmacologically effective dose of a compound according to claim 1 or salt thereof, to a patient in need thereof.
